Pharmacovigilance in the Age of Legalized Cannabis: Using Social Media to Monitor Drug-Drug Interactions Between Immunosuppressants and Cannabis-Derived Products
BackgroundThrough an analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS), we explored the signal strength of adverse reactions (ADRs) related to myopathy caused by the
Primary outcome(s): Incidence, severity, outcome, duration, action taken, and causality of individual adverse events [Expected and Unexpected adverse events (Serious and Non-serious Adverse Events)] r
The FEARS datasets include adverse drug events for mulitpe periods( 2004Q1-2011Q4 ). The FDA released the datasets publicly. More information can be seen in the website of FDA:https://open.fda.gov/dat
